Amyotrophic lateral sclerosis in Limousin (Limoges area, France)

Neuroepidemiology
F ChazotM Dumas

Abstract

Several epidemiological studies of amyotrophic lateral sclerosis have suggested that this neurological disease is uniformly distributed throughout the world. We report here the only study providing data on the incidence of this disease in France. It is based on a retrospective study of the Limoges region (Limousin) which contains only one university department of neurology. The study, conducted from February 1, 1977, to February 1, 1985, was not limited to in- and out-patients seen at this department, as we also contacted other non-hospital doctors who might have examined such patients. The average normal incidence was found to be 0.91 per 100,000 population. The male:female ratio was 1.16:1, and the median age of onset was 65 years. Median survival was 20.7 months.

Citations

Aug 1, 1993·Journal of the Neurological Sciences·F NorrisH Norris
Oct 26, 2001·Journal of the Neurological Sciences·P M Worms
Dec 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A M Chancellor, C P Warlow
Jun 25, 2008·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Teresa SalasMaría Fajardo
Jun 17, 2010·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Colette DonaghyVictor Patterson
Jan 1, 1991·Mayo Clinic Proceedings·D B Williams, A J Windebank
Jan 13, 2005·Acta Neurologica Scandinavica·A A ArgyriouE Chroni
May 1, 1996·Neurologic Clinics·B R Brooks
Jun 30, 2006·Biochimica Et Biophysica Acta·L Van Den BoschW Robberecht
Jun 1, 1993·Acta Neurologica Scandinavica·M GiaghedduB Murgia
Oct 1, 1994·Acta Neurologica Scandinavica·L BettoniD Mancia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.